/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

T

Takafumi Nakano

Jichi Medical University(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

61

Papers

1.1K

Citations

18

h-index

28

i10-index

Takafumi Nakano is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Salivary Gland Tumors Diagnosis and Treatment & Ear and Head Tumors & Head and Neck Cancer Studies. The author has an h-index of 18, co-authored 52 publications.

ORCID: 0000-0003-4298-2041

Research Topics

Salivary Gland Tumors Diagnosis and Treatment Ear and Head Tumors Head and Neck Cancer Studies Oral and Maxillofacial Pathology Head and Neck Surgical Oncology

Papers by this author

works

<i><scp>HER</scp>2</i> and <i><scp>EGFR</scp></i> gene copy number alterations are predominant in high‐grade salivary mucoepidermoid carcinoma irrespective of <i><scp>MAML</scp>2</i> fusion status

2013 · Histopathology · 53 citations

https://doi.org/10.1111/his.12183

Takafumi Nakano Hidetaka Yamamoto Kazuki Hashimoto Sadafumi Tamiya

Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma

2015 · Human Pathology · 25 citations

https://doi.org/10.1016/j.humpath.2015.07.014

Toshimitsu Nishijima Hidetaka Yamamoto Takafumi Nakano Torahiko Nakashima

Primary mucoepidermoid carcinoma of the liver with CRTC1-MAML2 fusion: a case report

2019 · Diagnostic Pathology · 18 citations

https://doi.org/10.1186/s13000-019-0863-8

Jirô Watanabe Keita Kai Ken Tanikawa Mamoru Hiraki

Supplementary Material for: Possible Association between Cathepsin V and the Development of Placenta Accreta Spectrum Disorders

2019 · Figshare · 0 citations

https://doi.org/10.6084/m9.figshare.7712351

S Matsukawa Seiji Sumigama Tomomi Kotani Jing Wang

Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)

2025 · Frontiers in Immunology · 0 citations

https://doi.org/10.3389/fimmu.2024.1464419

Kuniaki Sato Satoshi Toh Taku Murakami Takafumi Nakano

Research topics

topics

Salivary Gland Tumors Diagnosis and Treatment

Ear and Head Tumors

Head and Neck Cancer Studies

Oral and Maxillofacial Pathology

Head and Neck Surgical Oncology

Chat about Author

Papers

Chat

Click to start Chat